☆ 4.6 Letter

Growth disturbances in children and adolescents receiving long-term tyrosine kinase inhibitor therapy for Chronic Myeloid Leukaemia or Philadelphia Chromosome-positive Acute Lymphoblastic Leukaemia

BRITISH JOURNAL OF HAEMATOLOGY (2019)

Get Full Text
Add to Collection

Journal

BRITISH JOURNAL OF HAEMATOLOGY
Volume 185, Issue 4, Pages 795-799

Publisher

WILEY
DOI: 10.1111/bjh.15633

Keywords

protein kinase inhibitors; chronic myeloid leukaemia; Philadelphia chromosome-positive acute lymphoblastic leukaemia; body height; growth

Categories

Hematology

Funding

  1. Bristol Myers Squibb [CA180-640]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.